Employer record no. 26549
CANBridge Pharmaceuticals Inc.
US DOL LCA disclosure data, FY2020 to FY2025
Total LCA filings
10
Certified
8
Denied
1
FY2025 filings
1
Filings by fiscal year
Peer rank
#2,550 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 2 | 1 | 1 | $140,000 | $121,909 |
| FY2022 | 3 | 2 | 0 | $160,218 | $130,104 |
| FY2023 | 3 | 3 | 0 | $151,012 | $118,560 |
| FY2024 | 1 | 1 | 0 | $86,000 | $71,490 |
| FY2025 | 1 | 1 | 0 | $77,407 | $66,331 |
What they file for
- director, strategic finance$163,4224
- associate director, strategic finance$140,0002
- global commercial lead$140,0002
- research associate$81,7042
Where
- burlington, ma6
- cambridge, ma1
- malden, ma1
- somerville, ma1
- watertown, ma1
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for CANBridge Pharmaceuticals Inc. and any other employer they watch.
Certification rate 80.0%How these numbers are computed